Risk factors

Scholar Rock Holding (SRRK) risk factors

Item 1A of every Scholar Rock Holding Corp. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open SRRK in Gloom →
Scholar Rock Holding's chart, financials and news, free in your browser.Open SRRK in Gloom →
  • FY2025 10-K risk factors
    69 risks14 new12 dropped24 reworded

    Transitioning from clinical development to commercialization for apitegromab in the United States and Europe.

    Filed Mar 03, 2026
  • FY2024 10-K risk factors
    67 risks

    Company is a clinical-stage biopharmaceutical firm reliant on pipeline candidates apitegromab and SRK-181.

    Filed Feb 27, 2025